Table 2 Characteristics of persons with at least one NAAT result, by EHR database, February 5–November 30, 2020
Explorys | Academic Health System | OneFlorida | ||||
|---|---|---|---|---|---|---|
Indicator | Patients Testeda n (%) | Test Positivity Rate, % | Patients Testeda n (%) | Test Positivity Rate, % | Patients Testeda n (%) | Test Positivity Rate, % |
Total Patients | 754,926 | 13.0 | 170,965 | 8.0 | 358,126 | 8.9 |
Age (Years)b | ||||||
Mean (SD) | 48.1 (21.8) | N/A | 47.9 (20.8) | N/A | 48.3 (22.4) | N/A |
Median (IQR) | 50 (31,65) | N/A | 48 (31,64) | N/A | 51 (31,66) | N/A |
0–17 | 61,741 (8.2) | 10.4 | 8879 (5.2) | 5.4 | 32,286 (9.0) | 7.4 |
18–44 | 266,189 (35.3) | 15.0 | 70,458 (41.2) | 8.1 | 121,398 (33.9) | 11.5 |
45–64 | 225,688 (29.9) | 13.8 | 51,724 (30.3) | 8.4 | 108,367 (30.3) | 8.7 |
65–74 | 110,972 (14.7) | 10.1 | 22,197 (13.0) | 7.3 | 54,394 (15.2) | 6.2 |
75+ | 88,135 (11.7) | 10.7 | 17,707 (10.4) | 8.4 | 41,681 (11.6) | 7.0 |
Unknown | 2201 (0.3) | 7.7 | 0 (0.0) | 0.0 | 0 (0.0) | 0.0 |
Sexb | ||||||
Male | 324,309 (43.0) | 13.4 | 72,236 (42.3) | 8.6 | 158,345 (44.2) | 9.5 |
Female | 430,316 (57.0) | 12.7 | 98,650 (57.7) | 7.6 | 199,294 (55.6) | 8.5 |
Unknown | 301 (0.0) | 9.6 | 79 (0.0) | 3.8 | 487 (0.1) | 3.9 |
Raceb,c | ||||||
American Indian or Alaska Native | N/A | N/A | 353 (0.2) | 11.3 | 445 (0.1) | 9.9 |
Asian/Pacific Islander | 8250 (1.1) | 14.7 | 2713 (1.6) | 5.9 | 6054 (1.7) | 7.0 |
Black/African American | 182,682 (24.2) | 14.7 | 63,085 (36.9) | 10.5 | 58,408 (16.3) | 12.2 |
Caucasian/ White | 503,362 (66.7) | 12.5 | 75,154 (44.0) | 4.3 | 168,678 (47.1) | 7.2 |
Other | 18,256 (2.4) | 17.7 | 11,732 (6.9) | 18.2 | 86,778 (24.2) | 9.8 |
Unknown | 46,713 (6.2) | 10.2 | 17,928 (10.5) | 8.1 | 37,763 (10.5) | 9.8 |
Ethnicityb | ||||||
Hispanic | 39,556 (5.2) | 20.7 | 4657 (2.7) | 19.6 | 57,507 (16.1) | 14.9 |
Non–Hispanic | 347,228 (46.0) | 13.6 | 147,258 (86.1) | 7.2 | 200,823 (56.1) | 7.7 |
Unknown | 368,962 (48.9) | 11.7 | 19,050 (11.1) | 10.9 | 99,796 (27.9) | 8.1 |
Baseline Comorbidities (Charlson Comorbidity Index Component)d | ||||||
Patients with > 1 comorbidity | 267,889 (35.5) | 11.6 | 43,763 (25.6) | 6.9 | 82,369 (23.0) | 6.3 |
Patients with > 2 comorbidities | 68,828 (9.1) | 11.6 | 36,723 (21.5) | 6.9 | 74,203 (20.7) | 6.2 |
AIDS | 1595 (0.2) | 11.8 | 1078 (0.6) | 9.1 | 1284 (0.4) | 6.2 |
Any Malignancy | 55,176 (7.3) | 8.8 | 8169 (4.8) | 4 | 22,154 (6.2) | 3.9 |
Cerebrovascul-ar Disease | 33,860 (4.5) | 9.7 | 5345 (3.1) | 7.4 | 9095 (2.5) | 6.5 |
Chronic Renal Failure | 62,044 (8.2) | 10.4 | 9816 (5.7) | 8.5 | 16,245 (4.5) | 7 |
Congestive Heart Failure | 43,240 (5.7) | 9.9 | 8947 (5.2) | 7.2 | 15,371 (4.3) | 6.3 |
COPD | 126,099 (16.7) | 11.1 | 15,644 (9.2) | 6.3 | 26,214 (7.3) | 6.4 |
Dementia | 12,675 (1.7) | 15.4 | 2436 (1.4) | 12.4 | 4104 (1.1) | 12.4 |
Diabetes | 90,328 (12.0) | 12.7 | 16,609 (9.7) | 8.6 | 27,708 (7.7) | 8 |
Diabetes w/ Sequelae | 53,551 (7.1) | 12.1 | 7336 (4.3) | 8.9 | 13,779 (3.8) | 7.4 |
Metastatic Solid Tumor | 10,305 (1.4) | 6.8 | 2146 (1.3) | 3.1 | 6023 (1.7) | 3.6 |
Moderate-Severe Liver Disease | 4702 (0.6) | 7.2 | 975 (0.6) | 5.1 | 1984 (0.6) | 3.8 |
Myocardial Infarction | 15,737 (2.1) | 9.1 | 3795 (2.2) | 6.7 | 6416 (1.8) | 4.9 |
Paralysis | 6848 (0.9) | 10.8 | 1103 (0.6) | 9.5 | 2241 (0.6) | 7.2 |
Peripheral Vascular Disease | 47,142 (6.2) | 9 | 8272 (4.8) | 6 | 11,979 (3.3) | 5.8 |
Rheumatitis | 14,750 (2.0) | 10.4 | 2044 (1.2) | 5.6 | 3974 (1.1) | 6.5 |
Ulcers | 10,450 (1.4) | 8.7 | 1301 (0.8) | 5.5 | 2369 (0.7) | 4.7 |
Various Cirrhodites | 28,297 (3.7) | 9.1 | 4822 (2.8) | 5.2 | 10,181 (2.8) | 4.9 |